Abnormal neuroimaging in a case of infant botulism

We present the first case of abnormal neuroimaging in a case of infant botulism. The patient presented with clinical findings of constipation, bulbar weakness and descending, symmetric motor weakness which are consistent with the classic findings of infant botulism. Magnetic resonance imaging (MRI),...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryan J Good (Author), Kevin eMessacar (Author), Nicholas V Stence (Author), Craig A Press (Author), Todd C Carpenter (Author)
Format: Book
Published: Frontiers Media S.A., 2015-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b64a8ee4dc8c45aa9e4aa47e2d19bd58
042 |a dc 
100 1 0 |a Ryan J Good  |e author 
700 1 0 |a Kevin eMessacar  |e author 
700 1 0 |a Nicholas V Stence  |e author 
700 1 0 |a Craig A Press  |e author 
700 1 0 |a Todd C Carpenter  |e author 
245 0 0 |a Abnormal neuroimaging in a case of infant botulism 
260 |b Frontiers Media S.A.,   |c 2015-12-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2015.00108 
520 |a We present the first case of abnormal neuroimaging in a case of infant botulism. The patient presented with clinical findings of constipation, bulbar weakness and descending, symmetric motor weakness which are consistent with the classic findings of infant botulism. Magnetic resonance imaging (MRI), however, revealed restricted diffusion in the brain and enhancement of the cervical nerve roots. Traditionally, normal neuroimaging was used to help differentiate infant botulism from other causes of weakness in infants. Abnormal neuroimaging is seen in other causes of weakness in an infant including metabolic disorders and hypoxic-ischemic injury but these diagnoses did not fit the clinical findings in this case. The explanation for the MRI abnormalities in the brain and cervical nerve roots is unclear as botulinum toxin acts at presynaptic nerve terminals and does not cross the blood-brain barrier. Possible explanations for the findings include inflammation from the botulinum toxin at the synapse, alterations in sensory signaling and retrograde transport of the botulinum toxin. The patient was treated with human botulism immune globulin and had rapid recovery in weakness. A stool sample from the patient was positive for Type A Clostridium Botulinum toxin eventually confirming the diagnosis of infant botulism. The findings in this case support use of human botulism immune globulin when the clinical findings are consistent with infant botulism despite the presence of MRI abnormalities in the brain and cervical nerve roots. 
546 |a EN 
690 |a Neuroimaging 
690 |a toxin 
690 |a Infant botulism 
690 |a Acute flaccid paralysis 
690 |a human botulism immune globulin 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 3 (2015) 
787 0 |n http://journal.frontiersin.org/Journal/10.3389/fped.2015.00108/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/b64a8ee4dc8c45aa9e4aa47e2d19bd58  |z Connect to this object online.